I Peace accelerates allogeneic iPSC-derived cell therapies with g high throughput method to identify a large number of donors with specific HLA haplotypes.
PALO ALTO, Calif., May 12, 2022 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up in the field of GMP cell manufacturing CDMO, announced that the company, in collaboration with Genequest Inc., a Tokyo-based direct-to-consumer genetic testing service provider, established a data-driven method to identify potential cell donors...
Asia’s first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts.
Revolutionary Ovarian Cancer Rapid Test Available Q4 2022 SINGAPORE, May 11, 2022 /PRNewswire/ -- Known as a pioneer in Asia's women's and fetal health industry, Singapore-based diagnostics developer, INEX Innovate has obtained a CE mark for its lead ovarian cancer product, the OvaCis® Rapid Test. Slated to launch in the EU and Southeast...
PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention
DAEJEON, South Korea, May 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to participate at Jefferies Global Healthcare Conference over June 8-10, 2022 in New York, NY. Also,...
Regional UK Laboratory Information Management System Contract Awarded to Citadel Health
BLACKPOOL, England, May 11, 2022 /PRNewswire/ -- A contract for the implementation of a new Laboratory Information Management System (LIMS) across all NHS pathology services in Lancashire & South Cumbria has been awarded to Citadel Health. The new single LIMS will replace four standalone systems across eight hospital sites, cutting costs via a common platform linking all laboratories for...
DetectedX Launches Radiology Online Learning Platform to the U.S. Market at SBI
The Intelligent Interactive Educational Technology from DetectedX has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SAVANNAH, Ga., May 11, 2022 /PRNewswire/ -- DetectedX announced today that it will launch its Radiology Online Learning Platform to radiologists in the United States at the SBI/ACR Breast Imaging Symposium 2022, in...
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates
Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 11, 2022 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced financial results for the first quarter of 2022, along with recent product highlights and corporate updates. "Our first-quarter...
WORLD BRAIN DAY 2022 IS DEDICATED TO BRAIN HEALTH FOR ALL
LONDON, May 11, 2022 /PRNewswire/ -- On Friday, July 22, the World Federation of Neurology (WFN) is hosting the 9th Annual World Brain Day. WFN is pleased to announce that this year's theme is Brain Health for All. The all-encompassing theme aims to spark a universal effort that will share crucial information needed to reduce the burden of brain disorders—for...
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022
GAITHERSBURG, Md. and SUZHOU, China, May 11, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments on its GalNAc-Liver-Targeting platforms and a progress report on its GalAhead™ technologies and programs at the TIDES USA 2022 Conference. TIDES 2022 is taking place...
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients
HANGZHOU, China and SHAOXING, China, May 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the Investigational New Drug (IND) application approval of ASC22 (Envafolimab) by U.S. Food and Drug Administration (FDA) for the indication of immune restoration/functional cure of human immunodeficiency virus 1 (HIV-1) infected patients. Human immunodeficiency virus (HIV) is estimated to infect...
RhoVac AB announces Database Lock in its clinical phase IIb trial of onilcamotide
STOCKHOLM, Sweden, May 11, 2022 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announced on May 10th, 2022, that its phase IIb study in prostate cancer, BRaVac, has reached "Database Lock". This means that all data from the trial is now finally reported, cleaned and "locked" in the data base. The next step will be analysis to produce...
